Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-05-14-Speech-2-281"

PredicateValue (sorted: default)
rdf:type
lpv_eu:Speech2
dcterms:Date
"2002-05-14"^^xsd:date2
dcterms:Is Part Of
lp_eu:Question Time (Commission)2
dcterms:Language
"es"^^xsd:language2
lpv:document identification number
"en.20020514.12.2-281"2
lpv:hasSubsequent
lp_eu:2002-05-14-Speech-2-2822
lpv:speaker
lp:Alonso José Puerta2
lpv:spokenAs
unknown; Izquierda Unida (1999-07-20--2004-07-19)3
substitute; AFCO (2002-01-17--2004-07-19)3
member; Delegation for relations with the countries of Central America and Mexico (2002-02-07--2004-07-19)3
vice-president; Parliament's Bureau (2002-01-15--2004-07-19)3
member_of_the_bureau; EUL/NGL (1999-10-13--2004-07-19)3
member; Committee on Regional Policy, Transport and Tourism (2002-01-17--2004-07-19)3
vice-president; European Parliament (2002-01-15--2004-07-19)3
lpv:translated text
"Question No 34 by Phillip Whitehead (): Will the Commission guarantee that in the new Action Plan on life sciences, the ethical implications of biotechnology and genetic research will remain under consideration without delaying potentially beneficial technologies such as genetic testing and pharmacogenomics and if so, how?"@en1
lpv:unclassifiedMetadata
"President."1
"Subject: Work of the European Group on Ethics"1

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph